WILMINGTON, Mass., March 9, 2015 /PRNewswire/ -- Implant
Sciences Corporation (OTCQB: IMSC), a leading manufacturer of
explosives trace detection (ETD) and drugs trace detection
solutions for homeland security applications, announced today that
it has received notification that the bid protest filed with the
Government Accountability Office (GAO) regarding the Company's
recent 1,170 unit ETD award under Solicitation HSTS04-14-R-CT2050
has been denied. The stop work order has been lifted and the TSA
order, initially issued on November 10,
2014, will ship according to TSA's delivery schedule.
"The GAO's decision validates TSA's original award of the
Explosives Trace Detection contract to Implant Sciences. This marks
Implant Sciences as the first small business to successfully
introduce new ETD technology into aviation security and achieve
approval through the TSA Qualified Products List process in over a
decade," stated Dr. Bill McGann,
President and CEO of Implant Sciences Corporation. "This award
further establishes Implant Sciences as a leader in Explosives
Trace Detection."
"We are pleased that the GAO has rendered its decision on the
protest," stated Implant Sciences' Vice President of Global Sales
and Marketing, Dr. Darryl Jones. "We
will begin executing on this order and look forward to its
fulfillment."
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing
advanced detection capabilities to counter and eliminate the
ever-evolving threats from explosives and drugs. The Company's team
of dedicated trace detection experts has developed proprietary
technologies used in its commercial products, thousands of which
have been sold across more than 50 countries worldwide. The
Company's ETDs have received approvals and certifications from
several international regulatory agencies including the TSA in the
U.S., ECAC in Europe, STAC in
France, the German Ministry of the
Interior, and CAAC in China. It
also received a GSN 2013 Homeland Security Award for "Best
Explosives Detection Solution". All Implant Sciences products
are recognized as Qualified Anti-Terrorism Technologies by the
Department of Homeland Security. For further details on the Company
and its products, please visit the Company's website at
www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking
statements," as that term is defined in the Private Securities
Litigation Reform Act of 1995. Such statements are based on
management's current expectations and are subject to risks and
uncertainties that could cause the Company's actual results to
differ materially from the forward-looking statements. Such risks
and uncertainties include, but are not limited to: the risk that
there is no guaranty that U.S. or foreign government and law
enforcement agencies or commercial consumers will purchase any of
our products or that any new products we may develop will be
accepted by the TSA or by such other governments, agencies or
consumers; economic, political and other risks associated with
international sales and operations could adversely affect our
sales; our business is subject to intense competition and rapid
technological change, and our success will depend on our ability to
develop and introduce new products; and other risks and
uncertainties described in our filings with the Securities and
Exchange Commission, including our most recent Forms 10-K, 10-Q and
8-K. Such statements are based on management's current expectations
and assumptions which could differ materially from the
forward-looking statements.
Contact:
Implant Sciences Corporation
Company Contact:
Mike Turmelle, Director
978-752-1700 x 116
or
Investor Contact:
Laurel Moody
646-810-0608
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/1170-unit-explosives-trace-detection-award-to-implant-sciences-confirmed-by-gao-300047040.html
SOURCE Implant Sciences Corporation